Keyphrases
Carcinoma
100%
Induced Cell Death
100%
Elemene
100%
Cisplatin-induced
100%
Human Bladder Cancer
100%
Cisplatin
62%
Bladder Cancer
37%
Cisplatin Cytotoxicity
37%
Antitumor Activity
25%
Chemosensitizer
25%
Cell Cycle Progression
12%
Cell Growth
12%
Cell Apoptosis
12%
Cell Proliferation
12%
Therapeutic Efficacy
12%
Breast
12%
Cervix
12%
DNA Fragmentation
12%
Systemic Chemotherapy
12%
Caspase-3
12%
Cisplatin Resistance
12%
Apoptotic Cell Death
12%
Natural Compounds
12%
Combination Treatment
12%
Increased Activity
12%
Small Cell Lung Carcinoma
12%
Small Cell Lung Cancer
12%
24-cell
12%
Caspase-dependent
12%
Cisplatin Sensitivity
12%
Modifying Factors
12%
Solid Carcinoma
12%
Preclinical Therapeutic Studies
12%
Bladder Cancer Cell Lines
12%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinoma
100%
Bladder Cancer
100%
Cisplatin
100%
Cytotoxicity
27%
Antitumor Activity
18%
Small Cell Lung Cancer
18%
Disease
9%
Chemotherapy
9%
Caspase
9%
Combination Therapy
9%
Caspase 3
9%
Natural Product
9%